Experts: HHS Review Proposal May Free Industry From Regulatory Red Tape
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
You may also be interested in...
The rule would mandate that agencies assess rules that affect small entities once every decade to ensure they were still appropriate.
The US FDA hopes to finalize or issue draft guidance documents on about 30 topics in fiscal year 2021.
The US HHS defends its recent decision to relieve the FDA from oversight of laboratory developed tests in a new FAQ sheet, saying the agency hardly ever enforced the premarket review of LDTs in the first place.